Chimeric antibodies for treatment of amyloid deposition diseases
US11530257B2 · kind B2 · utility
4Cited by
6References
8Claims
0Family size
Inventors
Key dates
| Filing date | Jun 28, 2018 |
| Grant date | Dec 20, 2022 |
| Priority date | — |
| Expiry date | Oct 26, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/34
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A chimeric mouse-human antibody for treatment of amyloid deposition diseases, pharmaceutical compositions comprising the antibody, methods and materials for producing the antibody, and methods for treating an amyloid deposition disease using the antibody and the pharmaceutical composition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.